secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001493152-26-007429
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical CEO to speak at SAGES NBT Innovation Weekend panel on endovascular robotics
--------------------------------------------------------------------------------

- CEO Harel Gadot will be a featured panelist at The Surgical Disruptive Technology Summit (Feb 19-21, 2026 in Houston, TX).
- Panel titled 'Endovascular Therapeutics: AI and Robotics' to highlight the LIBERTY Endovascular Robotic System.
- LIBERTY is FDA cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
- Limited market release commenced in late 2025; full market release planned at SIR conference in April 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226007429/0001493152-26-007429-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226007429/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-007429

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer